Carvedilol improves left ventricular diastolic dysfunction in patients with transfusion-dependent thalassemia

BACKGROUND: Iron overload cardiomyopathy is the most common cause of death in patients with transfusion-dependent thalassemia. AIM: The aim of this study was to determine the efficacy of carvedilol treatment in patients with transfusion-dependent thalassemia who had left ventricular diastolic dysfun...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvilairat, Suchaya, Charoenkwan, Pimlak, Saekho, Suwit, Tantiworawit, Adisak, Chattipakorn, Nipon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174640/
https://www.ncbi.nlm.nih.gov/pubmed/34103853
http://dx.doi.org/10.4103/apc.APC_63_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174640/
https://www.ncbi.nlm.nih.gov/pubmed/34103853
http://dx.doi.org/10.4103/apc.APC_63_20

Ejemplares similares